ASND smart money
Ascendis Pharma A/S (ASND): 2 insider buys, 12 top funds holding it, 9 ETF changes in the public filings.
Insider buys, 12 months$548k
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-08-18 | Bienaime Jean Jacques | Director | $493k | $245.85 |
| 2026-06-01 | Smith Scott Thomas | EVP & Chief Financial Officer | $56k | $223.32 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 24 | Orbimed Advisors LLC | ADD +41% | 1.45% | $79M |
| 38 | Ars Investment Partners, LLC | 2.11% | $47M | |
| 50 | Siren, L.L.C. | BUY | 0.70% | $30M |
| 51 | Dafna Capital Management LLC | ADD +3% | 2.43% | $11M |
| 53 | Eagle Health Investments LP | ADD +12% | 4.65% | $27M |
| 63 | Vestal Point Capital, LP | ADD +97% | 4.36% | $169M |
| 74 | First Turn Management, LLC | TRIM -48% | 1.65% | $12M |
| 76 | Polar Capital Holdings PLC | ADD +5% | 0.41% | $147M |
| 80 | Avoro Capital Advisors LLC | 11.87% | $1.2B | |
| 83 | Tri Locum Partners LP | TRIM -54% | 5.33% | $27M |
| 86 | Adar1 Capital Management, LLC | 0.30% | $6M | |
| 96 | Pfm Health Sciences, LP | 5.57% | $52M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| T. Rowe Price Capital Appreciation Equity ETF | BUY | +$93M | 2026-06-30 |
| T. Rowe Price Capital Appreciation Equity ETF | SELL | −$76M | 2026-06-30 |
| Sapient Quality Select ETF | ADD | +$29M | 2026-07-31 |
| American Century Focused Dynamic Growth ETF | BUY | +$10M | 2026-05-31 |
| American Century Focused Dynamic Growth ETF | TRIM | −$10M | 2026-05-31 |
| Ishares U.S. Healthcare ETF | BUY | +$7M | 2026-07-31 |
| Invesco Nasdaq Next Gen 100 ETF | BUY | +$7M | 2026-05-31 |
| Invesco Nasdaq Next Gen 100 ETF | SELL | −$6M | 2026-05-31 |
| Franklin Focused Dynamic Growth ETF | SELL | −$2M | 2026-06-30 |